Strokes, statistics and sophistry in trials of thrombolysis for acute myocardial infarction

This publication has 15 references indexed in Scilit:

• Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA)
  Journal of the American College of Cardiology, 1992
• Heparin-induced prolongation of partial thromboplastin time after thrombolysis: Relation to coronary artery patency
  Journal of the American College of Cardiology, 1992
• Confronting the issues of patient safety and investigator conflict of interest in an international clinical trial of myocardial reperfusion
  Journal of the American College of Cardiology, 1992
• ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction
  Published by Elsevier ,1992
• Principles and practice of coronary thrombolysis and conjunctive treatment
  The American Journal of Cardiology, 1991
• In-hospital mortality and clinical course of 20 891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin
  The Lancet, 1990
• Coronary Thrombolysis: Streptokinase or Recombinant Tissue-Type Plasminogen Activator?
  Annals of Internal Medicine, 1990
• Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
  New England Journal of Medicine, 1989
• TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1988
• Recombinant tissue plasminogen activator (rt-PA): Is it the thrombolytic agent of choice for an evolving acute myocardial infarction?
  The American Journal of Cardiology, 1987